Singh JA, Yu S, Chen L, Cleveland JD. Charges of whole joint substitute in the us: future projections to 2020–2040 utilizing the nationwide inpatient pattern. J Rheumatol. 2019;46:1134–40.
Goodman SB, Gallo J. Periprosthetic osteolysis: mechanisms, prevention and therapy. J Clin Med. 2019;8:2091.
Quicke JG, Conaghan PG, Corp N, Peat G. Osteoarthritis yr in overview 2021: epidemiology and remedy. Osteoarthritis Cartilage. 2022;30:196–206.
Hodges NA, Sussman EM, Stegemann JP. Aseptic and septic prosthetic joint loosening: Affect of biomaterial put on on immune cell perform, irritation, and an infection. Biomaterials. 2021;278:121127.
Mahon OR, Dunne A. Illness-associated particulates and joint irritation; mechanistic insights and potential therapeutic targets. Entrance Immunol. 2018;9:1145.
Dyskova T, Gallo J, Kriegova E. The function of the chemokine system in tissue response to prosthetic by-products resulting in periprosthetic osteolysis and aseptic loosening. Entrance Immunol. 2017;8:1026.
Delaisse JM, Andersen TL, Kristensen HB, Jensen PR, Andreasen CM, Soe Okay. Re-thinking the bone transforming cycle mechanism and the origin of bone loss. Bone. 2020;141: 115628.
Coury F, Peyruchaud O, Machuca-Gayet I. Osteoimmunology of bone loss in inflammatory rheumatic illnesses. Entrance Immunol. 2019;10:679.
Kanzaki H, Shinohara F, Kanako I, Yamaguchi Y, Fukaya S, Miyamoto Y, Wada S, Nakamura Y. Molecular regulatory mechanisms of osteoclastogenesis via cytoprotective enzymes. Redox Biol. 2016;8:186–91.
Agidigbi TS, Kim C. Reactive oxygen species in osteoclast differentiation and attainable pharmaceutical targets of ROS-mediated osteoclast illnesses. Int J Mol Sci. 2019;20:3576.
Schroder Okay. NADPH oxidases in bone homeostasis and osteoporosis. Free Radic Biol Med. 2019;132:67–72.
Solar KY, Wu Y, Xu J, Xiong W, Xu W, Li J, Solar Z, Lv Z, Wu XS, Jiang Q, et al. Niobium carbide (MXene) reduces UHMWPE particle-induced osteolysis. Bioact Mater. 2022;8:435–48.
Xian Y, Su Y, Liang J, Lengthy F, Feng X, Xiao Y, Lian H, Xu J, Zhao J, Liu Q, Tune F. Oroxylin A reduces osteoclast formation and bone resorption by way of suppressing RANKL-induced ROS and NFATc1 activation. Biochem Pharmacol. 2021;193: 114761.
Wegner AM, Haudenschild DR. NADPH oxidases in bone and cartilage homeostasis and illness: a promising therapeutic goal. J Orthop Res. 2020;38:2104–12.
Ochoa CD, Wu RF, Terada LS. ROS signaling and ER stress in heart problems. Mol Points Med. 2018;63:18–29.
Takac I, Schroder Okay, Zhang L, Lardy B, Anilkumar N, Lambeth JD, Shah AM, Morel F, Brandes RP. The E-loop is concerned in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem. 2011;286:13304–13.
Guerin S, Harty J, Thompson N, Bryan Okay. Hydrogen peroxide as an irrigation answer in arthroplasty—a possible contributing issue to the event of aseptic loosening. Med Hypotheses. 2006;66:1142–5.
Guerin SR, MacNiochaill R, O’Reilly P, O’Byrne J, Kelly DJ. A comparative research of the impact of hydrogen peroxide versus regular saline on the energy of the bone-cement interface. Biomed Mater Eng. 2007;17:379–86.
Goettsch C, Babelova A, Trummer O, Erben RG, Rauner M, Rammelt S, Weissmann N, Weinberger V, Benkhoff S, Kampschulte M, et al. NADPH oxidase 4 limits bone mass by selling osteoclastogenesis. J Clin Make investments. 2013;123:4731–8.
Solar J, Chen W, Li S, Yang S, Zhang Y, Hu X, Qiu H, Wu J, Xu S, Chu T. Nox4 promotes RANKL-induced autophagy and osteoclastogenesis by way of activating ROS/PERK/eIF-2alpha/ATF4 pathway. Entrance Pharmacol. 2021;12: 751845.
Romeo SG, Alawi KM, Rodrigues J, Singh A, Kusumbe AP, Ramasamy SK. Endothelial proteolytic exercise and interplay with non-resorbing osteoclasts mediate bone elongation. Nat Cell Biol. 2019;21:430–41.
Novack DV, Teitelbaum SL. The osteoclast: buddy or foe? Annu Rev Pathol. 2008;3:457–84.
Liu Y, Wang C, Wang G, Solar Y, Deng Z, Chen L, Chen Okay, Tickner J, Kenny J, Tune D, et al. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis by way of attenuating NFATc1 and ROS actions. Theranostics. 2019;9:4648–62.
Akisaka T, Yoshida H, Inoue S, Shimizu Okay. Group of cytoskeletal F-actin, G-actin, and gelsolin within the adhesion buildings in cultured osteoclast. J Bone Miner Res. 2001;16:1248–55.
Weng Y, Wang H, Li L, Feng Y, Xu S, Wang Z. Trem2 mediated Syk-dependent ROS amplification is important for osteoclastogenesis in periodontitis microenvironment. Redox Biol. 2021;40: 101849.
Solar YX, Xu AH, Yang Y, Li J. Position of Nrf2 in bone metabolism. J Biomed Sci. 2015;22:101.
Sanchez-de-Diego C, Pedrazza L, Pimenta-Lopes C, Martinez-Martinez A, Dahdah N, Valer JA, Garcia-Roves P, Rosa JL, Ventura F. NRF2 perform in osteocytes is required for bone homeostasis and drives osteocytic gene expression. Redox Biol. 2021;40: 101845.
Gallo J, Goodman SB, Konttinen YT, Wimmer MA, Holinka M. Osteolysis round whole knee arthroplasty: a overview of pathogenetic mechanisms. Acta Biomater. 2013;9:8046–58.
Loi F, Cordova LA, Pajarinen J, Lin TH, Yao Z, Goodman SB. Irritation, fracture and bone restore. Bone. 2016;86:119–30.
Bi H, Chen X, Gao S, Yu X, Xiao J, Zhang B, Liu X, Dai M. Key triggers of osteoclast-related illnesses and accessible methods for focused therapies: a overview. Entrance Med (Lausanne). 2017;4:234.
Lo JC, Grimsrud CD, Ott SM, Chandra M, Hui RL, Ettinger B. Atypical femur fracture incidence in ladies will increase with period of bisphosphonate publicity. Osteoporos Int. 2019;30:2515–20.
Shi M, Chen L, Xin Z, Wang Y, Wang W, Yan S. Bisphosphonates for the preservation of periprosthetic bone mineral density after whole joint arthroplasty: a meta-analysis of 25 randomized managed trials. Osteoporos Int. 2018;29:1525–37.
Zhang L, Yang Y, Liao Z, Liu Q, Lei X, Li M, Saijilafu, Zhang Z, Hong D, Zhu M, et al. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly via suppressing the JNK/c-Fos-NFATc1 cascade. Theranostics. 2020;10:6638–60.
Almeida M, Porter RM. Sirtuins and FoxOs in osteoporosis and osteoarthritis. Bone. 2019;121:284–92.
Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in most cancers. Most cancers Cell. 2020;38:167–97.
Mittler R. ROS are good. Developments Plant Sci. 2017;22:11–9.
Wang Y, Branicky R, Noe A, Hekimi S. Superoxide dismutases: twin roles in controlling ROS harm and regulating ROS signaling. J Cell Biol. 2018;217:1915–28.
Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D, Jiang F, Peng ZY. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev. 2019;2019:5080843.
Harris IS, DeNicola GM. The complicated interaction between antioxidants and ROS in most cancers. Developments Cell Biol. 2020;30:440–51.
Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016;1863:2977–92.
Wu C, Wang W, Tian B, Liu X, Qu X, Zhai Z, Li H, Liu F, Fan Q, Tang T, et al. Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro. Biochem Pharmacol. 2015;93:59–71.
Callaway DA, Jiang JX. Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal getting older and bone illnesses. J Bone Miner Metab. 2015;33:359–70.
Hu S, Xue Y, He J, Chen C, Solar J, Jin Y, Zhang Y, Shi Q, Rui Y. Irisin recouples osteogenesis and osteoclastogenesis to guard wear-particle-induced osteolysis by suppressing oxidative stress and RANKL manufacturing. Biomater Sci. 2021;9:5791–801.
Schroder Okay, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, Luedike P, Michaelis UR, Weissmann N, et al. Nox4 is a protecting reactive oxygen species producing vascular NADPH oxidase. Circ Res. 2012;110:1217–25.
Yang S, Zhang Y, Ries W, Key L. Expression of Nox4 in osteoclasts. J Cell Biochem. 2004;92:238–48.
Schroder Okay. NADPH oxidases in bone homeostasis and osteoporosis. Cell Mol Life Sci. 2015;72:25–38.
Solar X, Xie Z, Hu B, Zhang B, Ma Y, Pan X, Huang H, Wang J, Zhao X, Jie Z, et al. The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-kappab signaling. Redox Biol. 2020;28: 101309.
Kanzaki H, Shinohara F, Kajiya M, Kodama T. The Keap1/Nrf2 protein axis performs a task in osteoclast differentiation by regulating intracellular reactive oxygen species signaling. J Biol Chem. 2013;288:23009–20.
Hyeon S, Lee H, Yang Y, Jeong W. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation. Free Radic Biol Med. 2013;65:789–99.
Li ZM, Xu SY, Feng YZ, Cheng YR, Xiong JB, Zhou Y, Guan CX. The function of NOX4 in pulmonary illnesses. J Cell Physiol. 2021;236:1628–37.
Meng XM, Ren GL, Gao L, Yang Q, Li HD, Wu WF, Huang C, Zhang L, Lv XW, Li J. NADPH oxidase 4 promotes cisplatin-induced acute kidney damage by way of ROS-mediated programmed cell dying and irritation. Lab Make investments. 2018;98:63–78.
Knock GA. NADPH oxidase within the vasculature: Expression, regulation and signalling pathways; function in regular cardiovascular physiology and its dysregulation in hypertension. Free Radic Biol Med. 2019;145:385–427.
Zhang L, Haddouti EM, Welle Okay, Burger C, Wirtz DC, Schildberg FA, Kabir Okay. The consequences of biomaterial implant put on particles on osteoblasts. Entrance Cell Dev Biol. 2020;8:352.
Jin Y, Chen S, Li N, Liu Y, Cheng G, Zhang C, Wang S, Zhang J. Defect-related luminescent bur-like hydroxyapatite microspheres induced apoptosis of MC3T3-E1 cells by lysosomal and mitochondrial pathways. Sci China Life Sci. 2018;61:464–75.
Kalbacova M, Roessler S, Hempel U, Tsaryk R, Peters Okay, Scharnweber D, Kirkpatrick JC, Dieter P. The impact of electrochemically simulated titanium cathodic corrosion merchandise on ROS manufacturing and metabolic exercise of osteoblasts and monocytes/macrophages. Biomaterials. 2007;28:3263–72.
Huang W, Shang WL, Li DH, Wu WW, Hou SX. Simvastatin protects osteoblast in opposition to H2O2-induced oxidative harm by way of inhibiting the upregulation of Nox4. Mol Cell Biochem. 2012;360:71–7.
Xu G, Li X, Zhu Z, Wang H, Bai X. Iron overload induces apoptosis and cytoprotective autophagy regulated by ROS era in Mc3t3-E1 cells. Biol Hint Elem Res. 2021;199:3781–92.
Moon JS, Nakahira Okay, Chung KP, DeNicola GM, Koo MJ, Pabon MA, Rooney KT, Yoon JH, Ryter SW, Stout-Delgado H, Choi AM. NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages. Nat Med. 2016;22:1002–12.
Li L, Yu M, Li Y, Li Q, Yang H, Zheng M, Han Y, Lu D, Lu S, Gui L. Synergistic anti-inflammatory and osteogenic n-HA/resveratrol/chitosan composite microspheres for osteoporotic bone regeneration. Bioact Mater. 2021;6:1255–66.
Qu S, Bai Y, Liu X, Fu R, Duan Okay, Weng J. Examine on in vitro launch and cell response to alendronate sodium-loaded ultrahigh molecular weight polyethylene loaded with alendronate sodium put on particles to deal with the particles-induced osteolysis. J Biomed Mater Res A. 2013;101:394–403.
von Knoch M, Jewison DE, Sibonga JD, Sprecher C, Morrey BF, Loer F, Berry DJ, Scully SP. The effectiveness of polyethylene versus titanium particles in inducing osteolysis in vivo. J Orthop Res. 2004;22:237–43.
Wooley PH, Morren R, Andary J, Sud S, Yang SY, Mayton L, Markel D, Sieving A, Nasser S. Inflammatory responses to orthopaedic biomaterials within the murine air pouch. Biomaterials. 2002;23:517–26.
